Interferon alpha-n3

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alpha-n3
Drug Alias NameAlferon LDO (Low Dose Oral)干扰素α-n3Alferon LDOInterferon alfa-n3 human leukocyte derived (Alferon N Injection)Interferon-α-n3 +[9] 
ClassificationBiologics > Blood components
Mechanisms of ActionImmunomodulatorsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsPapillomavirus InfectionsHIV Infections
Global Approved IndicationsPapillomavirus Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1989/10/10
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesStem Cell Innovations
China Registration ClassN/A

Develop Information

Active CompaniesInterferon Sciences Inc
Inactive CompaniesAim Immunotech Inc
Active IndicationsPapillomavirus Infections
Inactive IndicationsHIV Infections

Other Information

ATC CodeL03AB
Related LinksWikipediaDrugBank